Please login to the form below

I have forgotten my password

Germany to set up eHealth council to promote healthcare technology

Plans new eHealth legislation in the Autumn

Novartis: novel antimalarial is 'game-changing'

Says cipargamin could be first new class of malaria drugs in 20 years

AstraZeneca signs $2bn deal to buy Almirall respiratory portfolio

Will boost its pipeline prospects and inhaled device capabilities

Meda agrees $3.1bn takeover of Italy's Rottapharm

Will gain specialty medicines and boost its emerging market presence

NICE set to block post-Velcade use of Revlimid

Watchdog's new draft guidance does not recommend Celgene blood cancer drug

Pfizer acquires Baxter Men C and encephalitis vaccines for $635m

Snaps up marketed vaccines and part of Baxter's Austrian manufacturing plant

Amgen cuts workforce and facilities despite profit leap

US biopharma plans 12-15 per cent workforce reduction

European licence for BMS/Pfizer's Eliquis in DVT and PE

Anticoagulant catches up with Bayer's Xarelto and Boehringer's Pradaxa

Merck Serono enters anti-PD-1 fray

Moves skin cancer antibody candidate into phase II trials

This month in 1989: the creation of Bristol-Myers Squibb

The emergence of a company with a new focus on healthcare and research

Managing pharma's uncertainty

Futures we can’t predict need a strategy we can’t plan
Channel strategy and orphan drugs

A plan for guiding decisions about a product's distribution channel is particularly relevant for orphan drugs, rare diseases or specialty medicines

More features

Roche wins European approval for new leukaemia drug

Gazyvaro now available for use in treatment of blood cancer in the EU
J&J’s Imbruvica wins new cancer indication

FDA backs drug’s use in chronic lymphocytic leukaemia patients with genetic mutation
Novartis' glaucoma combo cleared in Europe

Simbrinza approved to treat eye condition
Reckitt Benckiser confirms pharma spin-off plans

Will separate prescription and consumer health businesses
Amgen launches bowel cancer web portal in Spain

Aims to help healthcare professionals understand about personalised medicine
AZ signs two companion diagnostic deals

Will help identify patients suitable for treatment with lung cancer drugs
Plegridy approval underlines Biogen Idec's dominance in MS

And Tecfidera boosts pharma company’s second quarter financial results

More news

Latest appointments

Ferring's Inna Demidova moves to ELC

Takes up Russia and CIS role at the regulatory affairs specialist
Walgreens’ head of pharmacy to step down

Kermit Crawford plans to retire
Peix appoints online marketing manager

Marie Kruger joins German agency
Cipla names Adil Zainulbhai to board

He has experience at consulting firm McKinsey & Company
Milestone names chief medical officer

Francis Plat bring experience from Merck, Daiichi-Sankyo, Novartis and BMS to the role

More appointments

Featured jobs

Business Unit Director, Medical Communications, London, Circa £10...: Circa £100-120K

Business Development Manager - Healthcare Digital Media: Competitive salary and high commission

Account Executive: Competitive + excellent benefits
Fleishman-Hillard UK Ltd

Senior Account Manager, Consumer Health/ Digital focus, Excellent pack...: Excellent Package

Senior Account Director/ Account Director, Healthcare Brand Communicat...: Highly Competitive package

Director, Healthcare PR, London, Excellent Package: Excellent Package

Group Account Director, Healthcare Advertising, London £80-90K: £80-90K

Account Director - PR: Excellent salary and package
ID Search & Selection

Head of Consumer Health - Healthcare PR: Competitive

Senior Account Manager - PR: Excellent salary and package
ID Search & Selection

Medical Communications Business Leader, London, £100-120K: £100-120K

Digital Planner – Digital Agency – London: Competitive

Head of Client Services, London, Diverse communications agency, circa ...: Circa £80K

Head of Copy, Healthcare Advertising/ Multichannel Agency, SE England,...: Highly Competitive package

Account Director/ Senior Account Director, OTC - TV, Digital, PR, Lond...: Highly Competitive package

Global CEO, Healthcare PR, London or US, Industry leading package: Industry leading package

Senior Account Manager, Healthcare PR, London, Excellent Package: Excellent Package

Senior Account Executive, Consumer Health/ Medical Communications, Lon...: Highly Competitive package

Medical Writer/ Consultant, Market Access & HEOR, London, Very com...: Very competitive package

Business Unit Director, Medical Communications, London, Circa 75K: Circa £80K

Account Manager, Consumer Health/ Medical Communications, London: Highly Competitive package

Scientific Director, Medical Communications, London, Circa 80K: Circa £80K

Medical Writer, Consumer Health/ Medical Communications, London: Highly Competitive package

Joint Managing Director, Medical Communications, London, £100-120...: £100-120K

Subscribe to our email news alerts

PMHub

Add my company

Galbraith Wight

The GalbraithWight Business School deliver boths in-house and public training programmes including the only accredited diploma designed specifically to enable...

Latest intelligence

M3 improves personalisation of pharma engagement with doctors: Launches new messaging service on Doctors.net.uk...
Digital Futures 2014 slide deck: Full slides, including survey data, from PMLiVE's digital pharma marketing online event...
The Chinese diabetes challenge: Marketing, communications and commercial relationships in China are full of pitfalls for the unwary, but not without great potential ...